27a main st., LLC

60 morningside drive
ossining, new york 10562

NYS Entity Status
ACTIVE

NYS Filing Date
OCTOBER 01, 2014

NYS DOS ID#
4644416

County
WESTCHESTER

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - 27A MAIN ST., LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Greg David on NY: Why developing in Midtown remains a Herculean task
    Monday Jun 19, 2017



    To view the full story, click the title link.

    Source: Crain&apso;s New York Business
  • Pulse@MassChallenge Spurs Deals in Digital Health Lab’s 1st Session
    By Jeff Engel - Wednesday Jun 14, 2017

    The refrain among digital health startups is it can be difficult and time-consuming to convince hospitals and other healthcare organizations to try out their products, let alone buy them. Pulse@MassChallenge, a new Boston “lab” dedicated to supporting digital health ventures, matches startups with partner organizations—think hospitals, insurers, larger tech companies, nonprofits, and government entities—to collaborate […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Needham Joins Final Nike/USL HSG Top 25 With Upset of Longmeadow
    By mschneider - Tuesday Jun 20, 2017

    Source: US Lacrosse Magazine
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • New Approvals Show FDA Is Adapting to Precision Medicine
    By Frank Vinluan - Tuesday May 30, 2017

    The randomized controlled trial has long been held up as the gold standard for testing new drugs. But the nation’s top drug evaluator, Janet Woodcock, believes they aren’t necessary for all new experimental treatments. Randomized trials are long, expensive to run, and ultimately produce limited answers, she said at a medical conference last week. The […]

    Source: Xconomy New York
  • Lincoln-Sudbury Claims State Title to Round Out Final Nike/USL HSB Top 25
    By mschneider - Tuesday Jun 20, 2017

    Source: US Lacrosse Magazine
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Fit City: Taking Night-Life Cue, Gyms Lower the Lights
    By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017

    Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.

    Source: NYT > Home Page